VRX-480773
VRX-480773 is an efficient non-nucleoside reverse transcriptase inhibitor (NNRTI), used for HIV infection. VRX-480773 has high specificity for HIV-1, with an EC50 for wild-type HIV-1 being 0.14 nM. VRX-480773 does not inhibit HIV-2, HBV or HCV, and has no effect on human DNA polymerase α/β. VRX-480773 retains inhibitory activity against Efavirenz resistant strains, with EC50s mostly.
Product Specifications
CAS Number
878670-89-4
UNSPSC
12352005
Target
HIV; Reverse Transcriptase
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
O=C(NC1=CC=C(S(=O)(N)=O)C=C1Cl)CSC2=NN=C(Br)N2C3=C4C=CC=CC4=C(C5CC5)C=C3
Molecular Formula
C23H19BrClN5O3S2
Molecular Weight
592.92
References & Citations
[1]Zhang Z, et al. A novel nonnucleoside analogue that inhibits human immunodeficiency virus type 1 isolates resistant to current nonnucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother. 2007 Feb;51 (2) :429-37.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HIV-1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A05519-1-Dylight488 100 µg
Anti-SMOX Antibody Picoband® (Dylight488 Conjugate)
Sign In for Pricing
View Details orb2924098-02 100 µg
Recombinant Pig Cytochrome P450 4A25 (CYP4A25)
Sign In for Pricing
View Details